Testing effectiveness (Phase 2)Ended earlyNCT04053543What this trial is testingCXA-10 Study in Subjects With Pulmonary Arterial HypertensionWho this might be right forPAH Complexa, Inc. 33
Not applicableStudy completedNCT05703802What this trial is testingEstablishment of an ELISA for the Recognition of Procalcitonin Variants in Patients With Hyperprocalcitonemia.Who this might be right forSepsisPre-EclampsiaGranulomatosis With Polyangiitis+4 more University Hospital Muenster 30
Not applicableLooking for participantsNCT07236970What this trial is testingMulticenter Study on the Development of Pulmonary Arterial Hypertension Screening Models Based on Artificial Intelligence for Patients With Systemic SclerosisWho this might be right forPulmonary HypertensionSystemic Sclerosis (SSc)Systemic Sclerosis-Associated PAH Alejandro Cruz Utrilla 350
Post-approval studies (Phase 4)Study completedNCT01889966What this trial is testingVasoREACTivity Testing With Intravenous SILdenafil in Patients With Precapillary Pulmonary HypertensionWho this might be right forPulmonary Hypertension Associated With Connective Tissue Disease Kerckhoff Heart Center 10
Testing effectiveness (Phase 2)Ended earlyNCT03449524What this trial is testingPRIMEx - A Study of 2 Doses of Oral CXA-10 in Pulmonary Arterial Hypertension (PAH)Who this might be right forPAH Complexa, Inc. 69
Not applicableUnknownNCT03459716What this trial is testingEndothelial Biomarkers of Systemic Sclerosis-associated Pulmonary HypertensionWho this might be right forSclerodermaPulmonary Hypertension Louisiana State University Health Sciences Center in New Orleans 56
Not applicableLooking for participantsNCT05462574What this trial is testingRight Ventricle Lipid in Pulmonary Arterial Hypertension (PAH)Who this might be right forIdiopathic Pulmonary Arterial HypertensionHeritable Pulmonary Arterial HypertensionPulmonary Arterial Hypertension Associated With Connective Tissue Disease Vanderbilt University Medical Center 75
Testing effectiveness (Phase 2)Study completedNCT01086540What this trial is testingRituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)Who this might be right forSystemic Sclerosis-Associated PAH National Institute of Allergy and Infectious Diseases (NIAID) 57
Not applicableLooking for participantsNCT07184814What this trial is testingClinical Features and Prognosis of Takayasu's Arteritis With Pulmonary Arteries InvolvementWho this might be right forTakayasu Arteritis With Pulmonary Artery InvolvementPulmonary Arterial Hypertension Associated With Connective Tissue Disease China-Japan Friendship Hospital 150
Testing effectiveness (Phase 2)WithdrawnNCT00323024What this trial is testingDose Determination Safety and Activity Study of Inhaled NX1011 to Treat Pulmonary Arterial HypertensionWho this might be right forPulmonary Hypertension NITROX, LLC 72
Large-scale testing (Phase 3)Enrolling By InvitationNCT03683186What this trial is testingA Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label ExtensionWho this might be right forPAHPulmonary HypertensionPulmonary Arterial Hypertension+8 more United Therapeutics 1,000
Large-scale testing (Phase 3)WithdrawnNCT03726398What this trial is testingCompRehensive Phenotypic Characterization of Patients With Scleroderma-Associated ILD and PHWho this might be right forInterstitial Lung DiseaseSclerodermaPulmonary Hypertension Franz Rischard, DO
Large-scale testing (Phase 3)Ended earlyNCT04084678What this trial is testingRalinepag to Evaluate Effects on Exercise Capacity by CPET in Subjects With WHO Group 1 PHWho this might be right forPAHPulmonary HypertensionHypertension+8 more United Therapeutics 10
Testing effectiveness (Phase 2)Active Not RecruitingNCT02682511What this trial is testingOral Ifetroban to Treat Diffuse Cutaneous Systemic Sclerosis (SSc) or SSc-associated Pulmonary Arterial HypertensionWho this might be right forScleroderma, DiffuseScleroderma, SystemicScleroderma, Limited+5 more Cumberland Pharmaceuticals 34
Post-approval studies (Phase 4)Study completedNCT01042158What this trial is testingA Clinical Trial of Ambrisentan and Tadalafil in Pulmonary Arterial Hypertension Associated With Systemic SclerosisWho this might be right forPulmonary Arterial HypertensionSystemic SclerosisScleroderma Spectrum of Diseases+2 more Johns Hopkins University 25
Post-approval studies (Phase 4)Looking for participantsNCT05828147What this trial is testingAnti-CD20 Antibodies for Treatment of SLE-PAHWho this might be right forSystemic Lupus ErythematosusPulmonary Arterial Hypertension Chinese SLE Treatment And Research Group 50
Large-scale testing (Phase 3)UnknownNCT00864201What this trial is testingEvaluate the Use of Bosentan in Patients With Exercise Induced Pulmonary Arterial Hypertension Associated With Connective Tissue DiseaseWho this might be right forHypertension, PulmonaryConnective Tissue Disease Hamilton Health Sciences Corporation 10
Not applicableStudy completedNCT03889509What this trial is testingA Systematic Review of Factors Associated With Pulmonary Arterial Hypertension in Systemic SclerosisWho this might be right forPulmonary Arterial HypertensionSystemic Sclerosis London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's 63
Testing effectiveness (Phase 2)Study completedNCT02290613What this trial is testingEarly Treatment of Borderline Pulmonary Arterial Hypertension Associated With Systemic Sclerosis (SSc-APAH)Who this might be right forSystemic SclerosisPulmonary Hypertension Heidelberg University 38
Large-scale testing (Phase 3)Ended earlyNCT02657356What this trial is testingBardoxolone Methyl in Patients With Connective Tissue Disease-associated Pulmonary Arterial Hypertension - CATALYSTWho this might be right forConnective Tissue Disease-Associated Pulmonary Arterial Hypertension Biogen 202